Matas E - Search Results

1

HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.

Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T. Romero-Pinel L, et al. Among authors: matas e. Eur J Neurol. 2011 Feb;18(2):337-342. doi: 10.1111/j.1468-1331.2010.03148.x. Eur J Neurol. 2011. PMID: 20629714

2

Anticipation of age at onset in familial multiple sclerosis.

Romero-Pinel L, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Kremenchutzky M, Arbizu T. Romero-Pinel L, et al. Among authors: matas e. Eur J Neurol. 2010 Apr;17(4):572-5. doi: 10.1111/j.1468-1331.2009.02870.x. Epub 2009 Dec 7. Eur J Neurol. 2010. PMID: 20002735

3

Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.

Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T. Romero-Pinel L, et al. Among authors: matas e. J Neurol Sci. 2010 Nov 15;298(1-2):96-100. doi: 10.1016/j.jns.2010.07.026. Epub 2010 Sep 1. J Neurol Sci. 2010. PMID: 20810130

4

Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.

Romero-Pinel L, Martínez-Yélamos S, Bau L, Matas E, Gubieras L, María Pujal J, Morandeira F, Bas J, Arbizu T. Romero-Pinel L, et al. Among authors: matas e. Eur J Neurol. 2011 Oct;18(10):1258-62. doi: 10.1111/j.1468-1331.2011.03379.x. Epub 2011 Mar 21. Eur J Neurol. 2011. PMID: 21418440

5

Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies.

Cobo-Calvo Á, Alentorn A, Mañé Martínez MA, Bau L, Matas E, Bruna J, Romero-Pinel L, Martínez-Yélamos S. Cobo-Calvo Á, et al. Among authors: matas e. Eur Neurol. 2014;72(1-2):86-94. doi: 10.1159/000358512. Epub 2014 Jun 14. Eur Neurol. 2014. PMID: 24942967

6

Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients.

Matas E, Bau L, Martínez-Iniesta M, Romero-Pinel L, Mañé MA, Cobo-Calvo Á, Martínez-Yélamos S. Matas E, et al. PLoS One. 2014 Nov 14;9(11):e112758. doi: 10.1371/journal.pone.0112758. eCollection 2014. PLoS One. 2014. PMID: 25396411 Free PMC article.

7

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.

Martínez MA, Olsson B, Bau L, Matas E, Cobo Calvo Á, Andreasson U, Blennow K, Romero-Pinel L, Martínez-Yélamos S, Zetterberg H. Martínez MA, et al. Among authors: matas e. Mult Scler. 2015 Apr;21(5):550-61. doi: 10.1177/1352458514549397. Epub 2015 Mar 2. Mult Scler. 2015. PMID: 25732842 Free PMC article.

8

Effectiveness of natalizumab in patients with highly active relapsing remitting multiple sclerosis.

Cobo-Calvo Á, Bau L, Matas E, Romero-Pinel L, Mañé Martínez MA, Majós C, Martínez Yélamos S. Cobo-Calvo Á, et al. Among authors: matas e. Eur Neurol. 2015;73(3-4):220-229. doi: 10.1159/000375371. Epub 2015 Mar 13. Eur Neurol. 2015. PMID: 25792347

9

MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.

Matas E, Bau L, Martínez-Iniesta M, Romero-Pinel L, Mañé-Martínez MA, Cobo-Calvo Á, Martínez-Yélamos S. Matas E, et al. J Neuroimmunol. 2016 Feb 15;291:73-7. doi: 10.1016/j.jneuroim.2015.12.015. Epub 2015 Dec 30. J Neuroimmunol. 2016. PMID: 26857498

10

Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.

Matas E, Bau L, Martínez-Iniesta M, Romero-Pinel L, Mañé-Martínez MA, Martínez-Yélamos S. Matas E, et al. J Neurol. 2016 Apr;263(4):722-9. doi: 10.1007/s00415-016-8053-z. Epub 2016 Feb 12. J Neurol. 2016. PMID: 26872667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters